Title:

Price:

Provider:

Date:

Pages:

Type:

Companies referenced:

Available for Immediate Download

Summary:

Veloxis Pharmaceuticals A/S (VELO) - Pharmaceuticals &
Healthcare - Deals and Alliances Profile Summary Veloxis
Pharmaceuticals A/S (Veloxis) formerly LifeCycle Pharma A/S, is a
specialty pharmaceutical company. It developes therapies based on
its proprietary MeltDose reformulation technology platform. The
company’s products are mainly used for cardiovascular indications
and transplant immunosuppression. Veloxis’s product portfolio
includes LCP-Tacro, LCP-AtorFen, LCP-Feno and LCP-FenoChol.
LCP-FenoChol helps in the treatment of mixed dyslipidemia,
hypertriglyceridemia and hypercholesterolemia and is sold under the
brand name Fenoglide in the US. LCP-Tacro is another product
undergoing clinical development for suppression of the immune
response to avoid the rejection of transplanted organs. Veloxis
Pharmaceuticals A/S (VELO) - Pharmaceuticals & Healthcare -
Deals and Alliances Profile provides you comprehensive data and
trend analysis of the company's Mergers and Acquisitions
(M&As), partnerships and financings. The report provides
detailed information on Mergers and Acquisitions, Equity/Debt
Offerings, Private Equity, Venture Financing and Partnership
transactions recorded by the company over a five year period. The
report offers detailed comparative data on the number of deals and
their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from
proprietary in-house Pharmaceuticals & Healthcare eTrack deals
database, and primary and secondary research. Scope - Financial
Deals - Analysis of the company's financial deals including Mergers
and Acquisitions, Equity/Debt Offerings, Private Equity, Venture
Financing and Partnerships. - Deals by Year - Chart and table
displaying information encompassing the number of deals and value
reported by the company by year, for a five year period. - Deals by
Type - Chart and table depicting information including the number
of deals and value reported by the company by type such as Mergers
and Acquisitions, Equity/Debt Offering etc. - Deals by Region -
Chart and table presenting information on the number of deals and
value reported by the company by region, which includes North
America, Europe, Asia Pacific, the Middle East and Africa and South
and Central America. - Deals by Sub-sector - Chart and table
showing information on the number of deals and value reported by
the company, by sub-sector. - Major Deals - Information on the
company's major financial deals. Each such deal has a brief
summary, deal type, deal rationale; and deal financials and target
Company's (major public companies) key financial metrics and
ratios. - Business Description - A brief description of the
company's operations. - Key Employees - A list of the key
executives of the company. - Important Locations and Subsidiaries -
A list and contact details of key centers of operation and
subsidiaries of the company. - Key Competitors - A list of the key
competitors of the company. - Key Recent Developments - A brief on
recent news about the company. Reasons to Buy Get detailed
information on the company's financial deals that enable you to
understand the company's expansion/divestiture and fund
requirements - The profile enables you to analyze the company's
financial deals by region, by year, by business segments and by
type, for a five year period. Understand the company's business
segments' expansion / divestiture strategy - The profile presents
deals from the com...

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.